Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves-Alain Barde

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody librarySpyros Merkouris, Yves-Alain Barde, Kate E Binley, et al.
American Journal of Human Genetics|September 22, 2009
Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucomaFrancesca Pasutto, Tomoya Matsumoto, Christian Y Mardin, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody librarySpyros Merkouris, Yves-Alain Barde, Kate E Binley, et al.
American Journal of Human Genetics|September 22, 2009
Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucomaFrancesca Pasutto, Tomoya Matsumoto, Christian Y Mardin, et al.
Pageof 5